Get startedLog in
    Picture of Carisma Therapeutics logo

    CARM — Carisma Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Sesen Bio Announces Anticipated Regulatory Path Forward For Vicineum™

    Picture of Carisma Therapeutics logoCarisma Therapeutics
    09/12/2021 13:09
    Dec 9 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO ANNOUNCES ANTICIPATED REGULATORY PATH FORWARD
FOR
VICINEUM™
    * SESEN BIO INC - PLANS TO CONDUCT AN ADDITIONAL CLINICAL
TRIAL
FOR POTENTIAL RESUBMISSION OF BLA FOR VICINEUM
    * SESEN BIO INC - EXPECTS TO HOLD A TYPE C MEETING WITH FDA
IN
EARLY 2022 TO DISCUSS CLINICAL TRIAL PROTOCOL FOR VICINEUM

Source text for Eikon:  ID:nBw6lxLlqa 
Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Carisma Therapeutics

    See all news